Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125528701 | 12552870 | 1 | I | 2016 | 20160429 | 20160713 | 20160713 | EXP | PHHY2016US063091 | SANDOZ | 81.32 | YR | F | Y | 0.00000 | 20160713 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125528701 | 12552870 | 1 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 10 MG, BID | Y | 0 | 10 | MG | TABLET | BID | |||||
125528701 | 12552870 | 2 | PS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 80336 | ||||||||||
125528701 | 12552870 | 3 | C | LASIX | FUROSEMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 4 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 5 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 7 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 8 | C | VITAMIN B | VITAMIN B | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 10 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 11 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 12 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 18 UG, UNK | U | 0 | 18 | UG | INHALER | ||||||
125528701 | 12552870 | 13 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 14 | C | ALBUTEROL. | ALBUTEROL | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 15 | C | LEVAQUIN | LEVOFLOXACIN | 1 | Intravenous (not otherwise specified) | 500 MG, UNK | U | 0 | 500 | MG | |||||||
125528701 | 12552870 | 16 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 17 | C | HEPARIN | HEPARIN SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 18 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 19 | C | NYSTATIN. | NYSTATIN | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 20 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 21 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Unknown | UNK | U | 0 | |||||||||
125528701 | 12552870 | 22 | C | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125528701 | 12552870 | 1 | Myelofibrosis |
125528701 | 12552870 | 2 | Pulmonary oedema |
125528701 | 12552870 | 3 | Product used for unknown indication |
125528701 | 12552870 | 4 | Product used for unknown indication |
125528701 | 12552870 | 5 | Product used for unknown indication |
125528701 | 12552870 | 6 | Product used for unknown indication |
125528701 | 12552870 | 7 | Product used for unknown indication |
125528701 | 12552870 | 8 | Product used for unknown indication |
125528701 | 12552870 | 9 | Product used for unknown indication |
125528701 | 12552870 | 10 | Product used for unknown indication |
125528701 | 12552870 | 11 | Product used for unknown indication |
125528701 | 12552870 | 12 | Product used for unknown indication |
125528701 | 12552870 | 13 | Product used for unknown indication |
125528701 | 12552870 | 14 | Product used for unknown indication |
125528701 | 12552870 | 15 | Product used for unknown indication |
125528701 | 12552870 | 16 | Product used for unknown indication |
125528701 | 12552870 | 17 | Product used for unknown indication |
125528701 | 12552870 | 18 | Product used for unknown indication |
125528701 | 12552870 | 19 | Product used for unknown indication |
125528701 | 12552870 | 20 | Product used for unknown indication |
125528701 | 12552870 | 21 | Product used for unknown indication |
125528701 | 12552870 | 22 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125528701 | 12552870 | OT |
125528701 | 12552870 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125528701 | 12552870 | Anaemia | |
125528701 | 12552870 | Asthenia | |
125528701 | 12552870 | Candida infection | |
125528701 | 12552870 | Chills | |
125528701 | 12552870 | Contusion | |
125528701 | 12552870 | Cough | |
125528701 | 12552870 | Decreased appetite | |
125528701 | 12552870 | Disease progression | |
125528701 | 12552870 | Electrolyte imbalance | |
125528701 | 12552870 | Fatigue | |
125528701 | 12552870 | Herpes zoster | |
125528701 | 12552870 | Hypertension | |
125528701 | 12552870 | Joint swelling | |
125528701 | 12552870 | Nausea | |
125528701 | 12552870 | Oropharyngeal pain | |
125528701 | 12552870 | Platelet count decreased | |
125528701 | 12552870 | Pulmonary oedema | |
125528701 | 12552870 | Sepsis | |
125528701 | 12552870 | Thrombocytopenia | |
125528701 | 12552870 | Urinary tract infection | |
125528701 | 12552870 | Vomiting | |
125528701 | 12552870 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125528701 | 12552870 | 1 | 2013 | 20160329 | 0 |